Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > short interest

<< Previous

Bullboard Posts

Next >>

Post by spesestsemperon Apr 23, 2024 10:40am

215 Views

Post# 36003204

short interest

Does anyone have a reliable way to find out the short interest on both the nasdaq and tsx

This site shows 930,654 shares short as of march 28

Seems a bit high , if decent news comes out .

Oncolytics Biotech, Inc. Common Shares (ONCY) Short Interest | Nasdaq

I cant find the short interest for the canadian market .

Not sure why they wouldnt close their short positions at this level . Downside is only a buck and i would think the company would maintain that level for the nasdaq listing . They are going to have a hard time if decent news appears . any idea why they wouldnt cover ?

<< Previous

Bullboard Posts

Next >>

Junior helium stock to benefit from new legislation in U.S.